单细胞转录组解析HER2+乳腺癌的免疫微环境重塑及细胞通讯特征
Single-Cell Transcriptomic Analysis of Immune Microenvironment Remodeling and Cell-Cell Communication Features in HER2-Positive Breast Cancer
DOI: 10.12677/bp.2025.151009, PDF,    科研立项经费支持
作者: 王浩波*, 李志豪, 于鸿浩, 岳鹏鹏#:广西高校医药生物技术与转化医学重点实验室,广西 桂林;罕见病防治广西高校工程研究中心,广西 桂林;桂林医学院智能医学与生物技术学院,广西 桂林
关键词: HER2+乳腺癌单细胞RNA测序细胞通讯免疫微环境HER2+ Breast Cancer Single-Cell RNA Sequencing Cell-Cell Communication Immune Microenvironment
摘要: 目的:本研究旨在利用单细胞转录组测序(scRNA-seq)分析HER2+乳腺癌(PT组)与正常乳腺组织(NM组)之间的细胞组成及细胞通讯差异,以探讨乳腺癌微环境的变化及其潜在的分子机制。方法:数据来源于Gene Expression Omnibus (GEO)数据库的GSE161529数据集,共包含3例HER2+乳腺癌患者(PT组)和3例健康乳腺组织样本(NM组)。本研究利用Seurat进行单细胞数据分析,基于差异表达基因(DEGs)进行Gene Ontology (GO)功能富集分析,并采用CellChat解析细胞–细胞相互作用网络,以识别HER2+乳腺癌微环境中的关键信号通路。结果:通过UMAP聚类分析,共鉴定出8种主要细胞类型。与NM组相比,PT组中B细胞、T/NK细胞、上皮细胞和髓系细胞的比例显著升高,而内皮细胞、成纤维细胞和嗜碱性粒细胞比例下降,肥大细胞无显著变化。差异基因分析显示,PT组显著上调的基因富集于免疫应答、细胞增殖及代谢重编程相关通路,而下调基因主要涉及核糖体生物合成、RNA代谢及蛋白翻译等过程。此外,CellChat分析揭示,PT组的细胞通讯显著增强,特别是FN1、MIF和APP信号通路的活跃,涉及细胞外基质重塑、炎症调控及免疫逃逸。结论:HER2+乳腺癌组织的细胞通讯模式发生了显著变化,肿瘤微环境的重塑可能通过增强特定信号通路促进癌症进展。
Abstract: Objective: This study aims to analyze the differences in cellular composition and cell-cell communication between HER2+ breast cancer (PT group) and normal breast tissue (NM group) using single-cell RNA sequencing (scRNA-seq), to explore microenvironmental alterations and their potential molecular mechanisms. Methods: The dataset GSE161529 was obtained from the Gene Expression Omnibus (GEO) database, including three HER2+ breast cancer samples (PT group) and three healthy breast tissue samples (NM group). Single-cell data analysis was performed using the Seurat package, differentially expressed genes (DEGs) were subjected to Gene Ontology (GO) functional enrichment analysis, and CellChat was used to construct the cell-cell interaction network to identify key signaling pathways in the HER2+ breast cancer microenvironment. Results: UMAP clustering analysis identified eight major cell types. Compared to the NM group, the PT group exhibited a significant increase in B cells, T/NK cells, epithelial cells, and myeloid cells, while endothelial cells, fibroblasts, and basophils were decreased, with mast cells showing no significant changes. Differential gene expression analysis revealed that upregulated genes in the PT group were enriched in immune response, cell proliferation, and metabolic reprogramming pathways, whereas downregulated genes were primarily associated with ribosome biogenesis, RNA metabolism, and protein translation. Furthermore, CellChat analysis demonstrated enhanced cell-cell communication in the PT group, particularly in FN1, MIF, and APP signaling pathways, which are involved in extracellular matrix remodeling, inflammation regulation, and immune evasion. Conclusion: The cell-cell communication network in HER2+ breast cancer undergoes significant alterations, and microenvironmental remodeling may contribute to cancer progression by activating specific signaling pathways.
文章引用:王浩波, 李志豪, 于鸿浩, 岳鹏鹏. 单细胞转录组解析HER2+乳腺癌的免疫微环境重塑及细胞通讯特征[J]. 生物过程, 2025, 15(1): 58-66. https://doi.org/10.12677/bp.2025.151009

参考文献

[1] Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30. [Google Scholar] [CrossRef] [PubMed]
[2] Torre, L.A., Sauer, A.M.G., Chen, M.S., Kagawa‐Singer, M., Jemal, A. and Siegel, R.L. (2016) Cancer Statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging Incidence in Males and Females. CA: A Cancer Journal for Clinicians, 66, 182-202. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[4] Vanguri, R.S., Fenn, K.M., Kearney, M.R., Wang, Q., Guo, H., Marks, D.K., et al. (2022) Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clinical Breast Cancer, 22, 538-546. [Google Scholar] [CrossRef] [PubMed]
[5] Bhat-Nakshatri, P., Gao, H., Sheng, L., McGuire, P.C., Xuei, X., Wan, J., et al. (2021) A Single-Cell Atlas of the Healthy Breast Tissues Reveals Clinically Relevant Clusters of Breast Epithelial Cells. Cell Reports Medicine, 2, Article 100219. [Google Scholar] [CrossRef] [PubMed]
[6] Viscido, G., Gambardella, G. and di Bernardo, D. (2021) Abstract 214: The Breast Single-Cell Atlas: Single-Cell Transcriptomics for Personalised Medicine. Cancer Research, 81, 214-214. [Google Scholar] [CrossRef
[7] Fernández-Nogueira, P., Mancino, M., Fuster, G., López-Plana, A., Jauregui, P., Almendro, V., et al. (2020) Tumor-Associated Fibroblasts Promote Her2-Targeted Therapy Resistance through FGFR2 Activation. Clinical Cancer Research, 26, 1432-1448. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, Y., Fang, Y., Bao, L., Wu, F., Wang, S. and Hao, S. (2022) Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. Biomolecules, 12, Article 1478. [Google Scholar] [CrossRef] [PubMed]
[9] Criscitiello, C., Vingiani, A., Maisonneuve, P., Viale, G., Viale, G. and Curigliano, G. (2020) Tumor-Infiltrating Lymphocytes (TILs) in ER+/HER2− Breast Cancer. Breast Cancer Research and Treatment, 183, 347-354. [Google Scholar] [CrossRef] [PubMed]
[10] DeNardo, D.G. and Ruffell, B. (2019) Macrophages as Regulators of Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 19, 369-382. [Google Scholar] [CrossRef] [PubMed]
[11] Qian, B. and Pollard, J.W. (2010) Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell, 141, 39-51. [Google Scholar] [CrossRef] [PubMed]
[12] Gabrilovich, D.I., Ostrand-Rosenberg, S. and Bronte, V. (2012) Coordinated Regulation of Myeloid Cells by Tumours. Nature Reviews Immunology, 12, 253-268. [Google Scholar] [CrossRef] [PubMed]
[13] Baselga, J. and Swain, S.M. (2009) Novel Anticancer Targets: Revisiting ERBB2 and Discovering ERBB3. Nature Reviews Cancer, 9, 463-475. [Google Scholar] [CrossRef] [PubMed]
[14] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[15] Saini, S.S. (2023) Urticaria and Basophils. Allergology International, 72, 369-374. [Google Scholar] [CrossRef] [PubMed]
[16] Varricchi, G., Galdiero, M.R., Loffredo, S., Marone, G., Iannone, R., Marone, G., et al. (2017) Are Mast Cells Masters in Cancer? Frontiers in Immunology, 8, Article 424. [Google Scholar] [CrossRef] [PubMed]
[17] Ben Dori, S., Aizic, A., Zubkov, A., Tsuriel, S., Sabo, E. and Hershkovitz, D. (2022) The Risk of PD-L1 Expression Misclassification in Triple-Negative Breast Cancer. Breast Cancer Research and Treatment, 194, 297-305. [Google Scholar] [CrossRef] [PubMed]
[18] Wherry, E.J. and Kurachi, M. (2015) Molecular and Cellular Insights into T Cell Exhaustion. Nature Reviews Immunology, 15, 486-499. [Google Scholar] [CrossRef] [PubMed]
[19] Fan, C., Tang, Y., Wang, J., Xiong, F., Guo, C., Wang, Y., et al. (2017) Role of Long Non-Coding Rnas in Glucose Metabolism in Cancer. Molecular Cancer, 16, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, X., Luo, J. and Wu, L. (2022) FN1 Overexpression Is Correlated with Unfavorable Prognosis and Immune Infiltrates in Breast Cancer. Frontiers in Genetics, 13, Article 913659. [Google Scholar] [CrossRef] [PubMed]
[21] Calandra, T. and Roger, T. (2003) Macrophage Migration Inhibitory Factor: A Regulator of Innate Immunity. Nature Reviews Immunology, 3, 791-800. [Google Scholar] [CrossRef] [PubMed]
[22] Lee, H.N., Jeong, M.S. and Jang, S.B. (2021) Molecular Characteristics of Amyloid Precursor Protein (APP) and Its Effects in Cancer. International Journal of Molecular Sciences, 22, Article 4999. [Google Scholar] [CrossRef] [PubMed]